Physician profile
Milu Thomas
NPI 1104366046
$3,198.17
in general payments reported to CMS, 2019-2025
29 companies · $808 in 2025
The $808 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,151 · 2022: $649 · 2023: $321 · 2024: $270 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $650.79 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $375.68 | 2021-2025 | Farxiga, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $362.43 | 2021-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Sanofi-Aventis U.S. LLC | $287.19 | 2021-2023 | |
| Novo Nordisk INC | $269.78 | 2021-2025 | Wegovy, Saxenda, Rybelsus |
| Janssen Pharmaceuticals, INC | $227.32 | 2021-2025 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $142.28 | 2022-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $123.75 | 2021-2025 | Zepbound, Mounjaro |
| Pfizer INC. | $96.56 | 2021-2025 | |
| Astellas Pharma US INC | $94.33 | 2024 | Veozah |
| Radius Health, INC. | $92.79 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $62.21 | 2021 | |
| Heartflow, INC. | $54.96 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.79 | 2022-2025 | |
| Daiichi Sankyo INC. | $40.23 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $39.02 | 2021-2025 | Watchman Flx |
| Amgen INC. | $29.26 | 2022-2025 | Prolia, Evenity |
| Exact Sciences Corporation | $28.58 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $19.73 | 2021 | |
| Avion Pharmaceuticals | $19.73 | 2021 | |
| Amarin Pharma, INC. | $19.13 | 2021 | |
| Ibsa Pharma INC. | $17.59 | 2021 | |
| Currax Pharmaceuticals LLC | $15.62 | 2024 | Contrave |
| Eisai INC. | $15.55 | 2021 | |
| Abbott Laboratories | $15.48 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.00 | 2023 | Quviviq |
| Seqirus USA INC | $14.58 | 2025 | Fluad, Flucelvax |
| Cranial Technologies, INC | $14.57 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milu Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.